Discover Funded Topics
Explore and discover Topics Funded by the NIH to see if you should apply
Funded Topics |
---|
Biochemistry | Biotechnology | Molecular Biology |
Synthetic Biology | Health Sciences | Informatics |
Digital Health | Mobile Health | Telehealth |
Life Sciences | Clinical Research and Early Clinical Trials | (Bio)Engineering in Medicine |
Immunology and Immuno-Oncology | Physics in Medicine | Neurosciences |
Neurobiology | Psychology | Social Sciences |
All other areas of healthcare |
NIH (National Institutes of Health)'s SBIR (R43/R44) and STTR (R41/R42) programs invest over $1B into health and life science companies that are creating innovative technologies that align with NIH (National Institutes of Health)'s mission to improve health and save lives. Several institutional centers (ICs) such as NCATS, NCI, NIBIB, NIDDK, NIA, NIGMS, NIMH, NINR, etc. all participate and welcome proposals. A key objective is to translate promising technologies to the private sector and enable life-saving innovations to reach consumer markets.
Phase I feasibility studies offer startups up to $300K of funding over 6-12 months, depending on the area of healthcare being focused upon. At the completion of the Phase I period, the company may compete for Phase II funding.
Phase II requires that the company has demonstrated feasibility of their work and is ready to for field testing (such as human trials or similar pre-commercialization testing). About $1.9M in funding can be requested for this phase.
Fast-Track (Phase I + Phase II) requires that both Phase I and Phase II applications are submitted and reviewed together as one application to reduce or eliminate the funding gap between phases.
Direct-to-Phase II (D2P2) is meant for small businesses that have already demonstrated substantial scientific and technical merit and feasibility but have not received a Phase I SBIR or STTR for that project.